Keyword Index

A

  • ABCC2 Transporter The Association between ATP-Binding Cassette C2 (ABCC2) Transporter Genetic Polymorphism and Peripheral Neuropathy in Gastrointestinal Cancer Patients Receiving Oxaliplatin. [Volume 8, Issue 1, 2024, Pages 1-12]
  • Acetyl cysteine Role of N-Acetyl Cysteine in the Management of Diabetic Peripheral Neuropathy: A Systematic Review [Volume 8, Issue 2, 2024, Pages 455-468]
  • Acinetobacter baumannii Evaluation of the antibacterial, antibiofilm, and cytotoxic activities of Peltophorum africanum leaf methanolic extract [Volume 8, Issue 1, 2024, Pages 177-188]
  • Algorithms Lead generation of Aurora-A kinase inhibitors: Using 3D-QSAR pharmacophore modeling, virtual screening, and molecular docking [Volume 8, Issue 2, 2024, Pages 207-223]
  • Alzheimer's disease Saxagliptin beyond glycemic control: a comprehensive review [Volume 8, Issue 2, 2024, Pages 386-395]
  • Alzheimer’s disease An Updated Review on the Neuroprotective Constituents of Genus Gardenia [Volume 8, Issue 2, 2024, Pages 275-289]
  • Anemia Pentoxifylline Reno-Protective and Anti-Inflammatory Effects and Potential Role in Anemia of Chronic Kidney Disease [Volume 8, Issue 2, 2024, Pages 261-274]
  • Anemia Relation between blood disorders in pregnancy and both mother and fetal health status [Volume 8, Issue 2, 2024, Pages 290-312]
  • Anticancer Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents [Volume 8, Issue 1, 2024, Pages 133-145]
  • Anticancer The Protective Properties of Luteolin: A Comprehensive Review [Volume 8, Issue 1, 2024, Pages 163-176]
  • Anti-inflammatory The Protective Properties of Luteolin: A Comprehensive Review [Volume 8, Issue 1, 2024, Pages 163-176]
  • Antimicrobial Endophytic bacteria as a source of novel bioactive compounds [Volume 8, Issue 2, 2024, Pages 469-496]
  • Antiviral agents Different Therapeutic Modalities for management of COVID-19 [Volume 8, Issue 1, 2024, Pages 76-108]
  • Apocynaceae Leveraging the cytotoxic attributes of Apocynaceae: current status and opportunities [Volume 8, Issue 2, 2024, Pages 356-371]
  • Aspergillus flocculosus Unearthing the Potential Secondary Metabolites Isolated from the Fungus Aspergillus flocculosus : A Comprehensive Review. [Volume 8, Issue 1, 2024, Pages 42-58]
  • Azelastine HCl Ion Selective Electrodes With Ionophore-Doped Sensing Membranes And Graphene Nanoplatelets For Determination Of Azelastine HCl In Nasal Spray And Plasma [Volume 8, Issue 2, 2024, Pages 313-327]

B

  • BDNF A Comprehensive Review of the Pathophysiology of Depression [Volume 8, Issue 1, 2024, Pages 122-132]
  • Benign prostatic hypertrophy An Environmentally Friendly Chromatographic Technique for Estimating Four Co-Administered Medications in Solid Dosage Forms and Human Plasma for the Treatment of Benign Prostatic Hyperplasia [Volume 8, Issue 2, 2024, Pages 224-244]
  • Bladder cancer Potential prospects of nanomaterials in bladder cancer treatment [Volume 8, Issue 2, 2024, Pages 396-426]

C

  • Carbon paste Ion Selective Electrodes With Ionophore-Doped Sensing Membranes And Graphene Nanoplatelets For Determination Of Azelastine HCl In Nasal Spray And Plasma [Volume 8, Issue 2, 2024, Pages 313-327]
  • Catharanthus roseus Leveraging the cytotoxic attributes of Apocynaceae: current status and opportunities [Volume 8, Issue 2, 2024, Pages 356-371]
  • Chemobrain Chemobrain: Insight the possible mechanisms of action induced by chemotherapeutic agents. [Volume 8, Issue 1, 2024, Pages 59-75]
  • Chemobrain Mechanisms and Protective Strategies in Cognitive Impairment Induced by Combination of Doxorubicin and Cyclophosphamide [Volume 8, Issue 1, 2024, Pages 109-121]
  • Chronic Kidney Disease Pentoxifylline Reno-Protective and Anti-Inflammatory Effects and Potential Role in Anemia of Chronic Kidney Disease [Volume 8, Issue 2, 2024, Pages 261-274]
  • Clinical trials Role of N-Acetyl Cysteine in the Management of Diabetic Peripheral Neuropathy: A Systematic Review [Volume 8, Issue 2, 2024, Pages 455-468]
  • CNS disorders An Updated Review on the Neuroprotective Constituents of Genus Gardenia [Volume 8, Issue 2, 2024, Pages 275-289]
  • COVID-19 Different Therapeutic Modalities for management of COVID-19 [Volume 8, Issue 1, 2024, Pages 76-108]
  • COVID-19 vaccination Different Therapeutic Modalities for management of COVID-19 [Volume 8, Issue 1, 2024, Pages 76-108]
  • Crocins An Updated Review on the Neuroprotective Constituents of Genus Gardenia [Volume 8, Issue 2, 2024, Pages 275-289]
  • Cytotoxicity Leveraging the cytotoxic attributes of Apocynaceae: current status and opportunities [Volume 8, Issue 2, 2024, Pages 356-371]

D

  • Dapoxetine An Environmentally Friendly Chromatographic Technique for Estimating Four Co-Administered Medications in Solid Dosage Forms and Human Plasma for the Treatment of Benign Prostatic Hyperplasia [Volume 8, Issue 2, 2024, Pages 224-244]
  • Diabetic neuropathy Role of N-Acetyl Cysteine in the Management of Diabetic Peripheral Neuropathy: A Systematic Review [Volume 8, Issue 2, 2024, Pages 455-468]
  • Discovery Lead generation of Aurora-A kinase inhibitors: Using 3D-QSAR pharmacophore modeling, virtual screening, and molecular docking [Volume 8, Issue 2, 2024, Pages 207-223]
  • DNA Extremely low frequency electromagnetic field (ELF-EMF) as a promising tool for treatment against multi-drug resistant bacteria [Volume 8, Issue 1, 2024, Pages 146-162]
  • Doxorubicin Mechanisms and Protective Strategies in Cognitive Impairment Induced by Combination of Doxorubicin and Cyclophosphamide [Volume 8, Issue 1, 2024, Pages 109-121]
  • DPP-4 Saxagliptin beyond glycemic control: a comprehensive review [Volume 8, Issue 2, 2024, Pages 386-395]
  • Drug Lead generation of Aurora-A kinase inhibitors: Using 3D-QSAR pharmacophore modeling, virtual screening, and molecular docking [Volume 8, Issue 2, 2024, Pages 207-223]

E

  • Endophytic bacteria Endophytic bacteria as a source of novel bioactive compounds [Volume 8, Issue 2, 2024, Pages 469-496]
  • Epigenetic Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents [Volume 8, Issue 1, 2024, Pages 133-145]
  • Ervatamia pandacaqui and Kopsia fruticosa Leveraging the cytotoxic attributes of Apocynaceae: current status and opportunities [Volume 8, Issue 2, 2024, Pages 356-371]

F

  • Fetal Health Relation between blood disorders in pregnancy and both mother and fetal health status [Volume 8, Issue 2, 2024, Pages 290-312]
  • Fungal sources Unearthing the Potential Secondary Metabolites Isolated from the Fungus Aspergillus flocculosus : A Comprehensive Review. [Volume 8, Issue 1, 2024, Pages 42-58]

G

  • Gardenia An Updated Review on the Neuroprotective Constituents of Genus Gardenia [Volume 8, Issue 2, 2024, Pages 275-289]
  • GLP-1 Saxagliptin beyond glycemic control: a comprehensive review [Volume 8, Issue 2, 2024, Pages 386-395]
  • Growth Extremely low frequency electromagnetic field (ELF-EMF) as a promising tool for treatment against multi-drug resistant bacteria [Volume 8, Issue 1, 2024, Pages 146-162]

H

  • High-fat diet Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy [Volume 8, Issue 2, 2024, Pages 245-260]
  • Histone deacetylase Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents [Volume 8, Issue 1, 2024, Pages 133-145]
  • HPA axis A Comprehensive Review of the Pathophysiology of Depression [Volume 8, Issue 1, 2024, Pages 122-132]
  • Hydroxypropyl beta-cyclodextrin Ion Selective Electrodes With Ionophore-Doped Sensing Membranes And Graphene Nanoplatelets For Determination Of Azelastine HCl In Nasal Spray And Plasma [Volume 8, Issue 2, 2024, Pages 313-327]
  • Hypersomnia Harnessing Melatonergic Agonists and Antagonists: A Dual Approach to Alleviating Depression and Depression-associated Insomnia [Volume 8, Issue 2, 2024, Pages 427-454]
  • Hypogen Lead generation of Aurora-A kinase inhibitors: Using 3D-QSAR pharmacophore modeling, virtual screening, and molecular docking [Volume 8, Issue 2, 2024, Pages 207-223]
  • Hypothalamic -pituitary-adrenal axis Pathophysiology of depression: inflammation and its relation with oxidative stress and the hypothalamic-pituitary-adrenal axis [Volume 8, Issue 1, 2024, Pages 13-28]
  • Hz Extremely low frequency electromagnetic field (ELF-EMF) as a promising tool for treatment against multi-drug resistant bacteria [Volume 8, Issue 1, 2024, Pages 146-162]

I

  • Inflammation Pathophysiology of depression: inflammation and its relation with oxidative stress and the hypothalamic-pituitary-adrenal axis [Volume 8, Issue 1, 2024, Pages 13-28]
  • Inflammation Chemobrain: Insight the possible mechanisms of action induced by chemotherapeutic agents. [Volume 8, Issue 1, 2024, Pages 59-75]
  • Inflammation Mechanisms and Protective Strategies in Cognitive Impairment Induced by Combination of Doxorubicin and Cyclophosphamide [Volume 8, Issue 1, 2024, Pages 109-121]
  • Inflammation Pentoxifylline Reno-Protective and Anti-Inflammatory Effects and Potential Role in Anemia of Chronic Kidney Disease [Volume 8, Issue 2, 2024, Pages 261-274]
  • Inflammatory cytokines A Comprehensive Review of the Pathophysiology of Depression [Volume 8, Issue 1, 2024, Pages 122-132]
  • Iridoids An Updated Review on the Neuroprotective Constituents of Genus Gardenia [Volume 8, Issue 2, 2024, Pages 275-289]
  • Iron Deficiency Relation between blood disorders in pregnancy and both mother and fetal health status [Volume 8, Issue 2, 2024, Pages 290-312]

K

  • Keyword: Chronic kidney disease The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review [Volume 8, Issue 2, 2024, Pages 372-385]

L

  • Lipopolysaccharide injection model Pathophysiology of depression: inflammation and its relation with oxidative stress and the hypothalamic-pituitary-adrenal axis [Volume 8, Issue 1, 2024, Pages 13-28]
  • Luteolin The Protective Properties of Luteolin: A Comprehensive Review [Volume 8, Issue 1, 2024, Pages 163-176]

M

  • Malignancy Potential prospects of nanomaterials in bladder cancer treatment [Volume 8, Issue 2, 2024, Pages 396-426]
  • Management Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy [Volume 8, Issue 2, 2024, Pages 245-260]
  • Maternal separation model Pathophysiology of depression: inflammation and its relation with oxidative stress and the hypothalamic-pituitary-adrenal axis [Volume 8, Issue 1, 2024, Pages 13-28]
  • Melatonin Harnessing Melatonergic Agonists and Antagonists: A Dual Approach to Alleviating Depression and Depression-associated Insomnia [Volume 8, Issue 2, 2024, Pages 427-454]
  • Melodinus cochinchinensis Leveraging the cytotoxic attributes of Apocynaceae: current status and opportunities [Volume 8, Issue 2, 2024, Pages 356-371]
  • Monoamines A Comprehensive Review of the Pathophysiology of Depression [Volume 8, Issue 1, 2024, Pages 122-132]
  • Multi-drug resistance Endophytic bacteria as a source of novel bioactive compounds [Volume 8, Issue 2, 2024, Pages 469-496]

N

  • Nanomaterials Potential prospects of nanomaterials in bladder cancer treatment [Volume 8, Issue 2, 2024, Pages 396-426]
  • Non-Alcoholic Steatohepatitis Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy [Volume 8, Issue 2, 2024, Pages 245-260]
  • Non-Small Cell Lung Cancer Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer [Volume 8, Issue 2, 2024, Pages 328-339]

O

  • Overall survival Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer [Volume 8, Issue 2, 2024, Pages 328-339]
  • Oxaliplatin The Association between ATP-Binding Cassette C2 (ABCC2) Transporter Genetic Polymorphism and Peripheral Neuropathy in Gastrointestinal Cancer Patients Receiving Oxaliplatin. [Volume 8, Issue 1, 2024, Pages 1-12]
  • Oxidative Stress Pathophysiology of depression: inflammation and its relation with oxidative stress and the hypothalamic-pituitary-adrenal axis [Volume 8, Issue 1, 2024, Pages 13-28]
  • Oxidative Stress Chemobrain: Insight the possible mechanisms of action induced by chemotherapeutic agents. [Volume 8, Issue 1, 2024, Pages 59-75]
  • Oxidative Stress Mechanisms and Protective Strategies in Cognitive Impairment Induced by Combination of Doxorubicin and Cyclophosphamide [Volume 8, Issue 1, 2024, Pages 109-121]

P

  • Parkinson's disease Saxagliptin beyond glycemic control: a comprehensive review [Volume 8, Issue 2, 2024, Pages 386-395]
  • Pentoxifylline Pentoxifylline Reno-Protective and Anti-Inflammatory Effects and Potential Role in Anemia of Chronic Kidney Disease [Volume 8, Issue 2, 2024, Pages 261-274]
  • Pharmacokinetics Association between UGT2B7 Genetic Polymorphism and Pharmacokinetics of Empagliflozin in Humans [Volume 8, Issue 2, 2024, Pages 340-355]
  • Polymorphism Association between UGT2B7 Genetic Polymorphism and Pharmacokinetics of Empagliflozin in Humans [Volume 8, Issue 2, 2024, Pages 340-355]
  • Pregnancy Relation between blood disorders in pregnancy and both mother and fetal health status [Volume 8, Issue 2, 2024, Pages 290-312]
  • Proteinuria Pentoxifylline Reno-Protective and Anti-Inflammatory Effects and Potential Role in Anemia of Chronic Kidney Disease [Volume 8, Issue 2, 2024, Pages 261-274]
  • Pseudomonas aeruginosa Evaluation of the antibacterial, antibiofilm, and cytotoxic activities of Peltophorum africanum leaf methanolic extract [Volume 8, Issue 1, 2024, Pages 177-188]

R

  • Reno-protective The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review [Volume 8, Issue 2, 2024, Pages 372-385]

S

  • Secondary metabolites, terpenoids, alkaloids, polyketides Unearthing the Potential Secondary Metabolites Isolated from the Fungus Aspergillus flocculosus : A Comprehensive Review. [Volume 8, Issue 1, 2024, Pages 42-58]
  • SGLT-2 inhibitors The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review [Volume 8, Issue 2, 2024, Pages 372-385]
  • Sleep architecture Harnessing Melatonergic Agonists and Antagonists: A Dual Approach to Alleviating Depression and Depression-associated Insomnia [Volume 8, Issue 2, 2024, Pages 427-454]
  • Social defeat stress model Pathophysiology of depression: inflammation and its relation with oxidative stress and the hypothalamic-pituitary-adrenal axis [Volume 8, Issue 1, 2024, Pages 13-28]

T

  • Tadalafil An Environmentally Friendly Chromatographic Technique for Estimating Four Co-Administered Medications in Solid Dosage Forms and Human Plasma for the Treatment of Benign Prostatic Hyperplasia [Volume 8, Issue 2, 2024, Pages 224-244]
  • Tamsulosin An Environmentally Friendly Chromatographic Technique for Estimating Four Co-Administered Medications in Solid Dosage Forms and Human Plasma for the Treatment of Benign Prostatic Hyperplasia [Volume 8, Issue 2, 2024, Pages 224-244]
  • Therapeutic modalities Different Therapeutic Modalities for management of COVID-19 [Volume 8, Issue 1, 2024, Pages 76-108]
  • Treatment Potential prospects of nanomaterials in bladder cancer treatment [Volume 8, Issue 2, 2024, Pages 396-426]

U

  • UGT2B7 Association between UGT2B7 Genetic Polymorphism and Pharmacokinetics of Empagliflozin in Humans [Volume 8, Issue 2, 2024, Pages 340-355]

V

  • Vaccine derived Vaccine-Derived Poliovirus: Epidemiology, Types, Global Response and Future Prospectives [Volume 8, Issue 1, 2024, Pages 29-41]